·
Price Band is fixed at ₹ 938 to ₹ 988 per Equity Share of face value of ₹ 2 each
·
The Bid /Offer opens on Monday, 24, 2026
and closes on Thursday, August 27, 2026. The Anchor Investor Bidding Date opens
and closes on Friday, August 21, 2026.
·
Bids can be made for a minimum of 15 Equity Shares and in
multiples of 15 Equity Shares thereafter.
·
Discount Of ₹ 90.00 per Equity
Share of Face Value of ₹2 is being offered to Eligible Employees Bidding in the Employee
Reservation Portion.
Mumbai: Symbiotec Pharmalab
Limited (“Symbiotec Pharmalab”
or “The Company”), proposes to open the Bid / Offer Period in relation to
its Initial Public Offer of the Equity Shares (“Offer”) on Monday, August 24, 2026.
The Offer comprises a fresh issue of such number of Equity Shares by the Company aggregating up to ₹1,500.00 million (“Fresh Issue”) and offer for sale of up to ₹16,070.00 million (“Offer for Sale”) by certain existing shareholders of the Company (the “Selling Shareholders”) (collectively, the “Total Offer Size”).
The
Company proposes to utilise the Net Proceeds towards Prepayment and/or
repayment, in full or in part, of all or a portion of certain outstanding
borrowings availed by the Company; and General corporate purposes. (the “Objects
of the Offer”)
The Offer for Sale comprises of such number of Equity Shares aggregating up to ₹1,440.00 million by Satwani Holdings LLP (the “Promoter Selling Shareholder”), of such number of Equity Shares aggregating up to ₹9,880.00 million by Rosewood Investments, and of such number of Equity Shares aggregating up to ₹4,750.00 million by India Business Excellence Fund – III (collectively, the “Investor Selling Shareholders”).
The Anchor Investor Bid/Offer Period opens and
closes on Friday, August 21, 2026.
The Bid/Offer Period will open on Monday, August 24, 2026, for subscription and close on Thursday, August 27, 2026. ( “Bid/Offer Period”).
The Price Band of the Offer has been fixed at ₹938 to ₹988 per Equity Share (the “Price Band”). Bids can be made for a minimum of 15 Equity Shares and in multiples of 15 Equity Shares thereafter (the “Bid Lot”). Discount Of ₹ 90.00 Per Equity Share of Face Value of ₹2 is being offered to Eligible Employees Bidding in the Employee Reservation Portion
This Equity Shares are being offered through
the Red Herring Prospectus of the Company dated August 18, 2026 filed with the Registrar of Companies at Madhya Pradesh at Gwalior ( “RoC”).
The Equity Shares to be offered through the Red Herring Prospectus are proposed to be listed on the stock exchanges being BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE” together with BSE, the “Stock Exchanges”). For the purposes of the Offer, BSE Limited is the Designated Stock Exchange. (The “Listing Details”)
JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal
Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited are the
book running lead managers to the Offer (“Book Running Lead Managers “or “BRLMs”).
All capitalised terms used herein but not defined shall have the same meaning as ascribed to them in the RHP.
This Offer is being made through the Book
Building Process, in terms of Rule 19(2)(b) of the Securities Contract
(Regulation) Rules, 1957 (“SCRR”) read with Regulation 31 of the SEBI
ICDR Regulations and in compliance with Regulation 6(1) of the SEBI ICDR
Regulations wherein not more than 50% of the Net Offer shall be available for
allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs”,
and such portion, the “QIB Portion”), provided that our Company, in
consultation with the BRLMs, may allocate up to 60% of the QIB Portion to
Anchor Investors on a discretionary basis (“Anchor Investor Portion”).
40% of the Anchor Investor Portion shall be reserved as under: (i) 33.33% for
the domestic Mutual Funds; and (ii) 6.67% for Life Insurance Companies and
Pension Funds, subject to valid Bids being received from the domestic Mutual
Funds, Life Insurance Companies and Pension Funds at or above the price at
which allocation will be made to Anchor Investors (“Anchor Investor
Allocation Price”) in accordance with the SEBI ICDR Regulations. Any
under-subscription in the reserved category specified in clause (ii) above may
be allocated to domestic Mutual Funds. In the event of under-subscription or
non-allocation in the Anchor Investor Portion, the balance Equity Shares shall
be added to the QIB Portion (other than the Anchor Investor Portion) (the “Net
QIB Portion”).
Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, subject to valid Bids being received at or above the Offer Price, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to QIB Bidders (other than Anchor Investors) including Mutual Funds subject to valid Bids being received at or above the Offer Price. However, if the aggregate demand from Mutual Funds is less than 5% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to all QIBs.
Further, not less than 15% of the Net
Offer shall be available for allocation to Non-Institutional Bidders (out of
which one-third of the portion available to Non-Institutional Bidders shall be
reserved for Bidders with an application size of more than ₹0.20 million and up
to ₹1.00 million and two-thirds shall be reserved for Bidders with an
application size of more than ₹1.00 million, provided that the unsubscribed
portion in either of the aforementioned sub-categories may be allocated to
Bidders in the other sub-category) and not less than 35% of the Net Offer shall
be available for allocation to Retail Individual Bidders in accordance with the
SEBI ICDR Regulations, subject to valid Bids being received from them at or
above the Offer Price. Further, Equity Shares will be allocated on a proportionate
basis to Eligible Employees applying under the Employee Reservation Portion,
subject to valid Bids received from them at or above the Offer Price. All
Bidders, other than Anchor Investors, are required to participate in the Offer
by mandatorily utilising the Application Supported by Blocked Amount (“ASBA”)
process by providing details of their respective ASBA Account (as defined
hereinafter) and UPI ID in case of UPI Bidders (as defined hereinafter), as
applicable, pursuant to which their corresponding Bid Amounts will be blocked
by the SCSBs or by the Sponsor Banks under the UPI Mechanism, as the case may
be, to the extent of respective Bid Amounts. Anchor Investors are not permitted
to participate in the Offer through the ASBA process. For further details, see
“Offer Procedure” on page 451 of RHP.